ArticlePloS one2022
How do the smart travel ban policy and intercity travel pattern affect COVID-19 trends? Lessons learned from Iran.
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Human mobility and outbreak origins in epidemic spread: Insights from agent-based modeling.PLoS computational biology · 2026Article
- Impact of COVID-19 pandemic on road traffic injuries in Iran: An interrupted time-series analysis.PloS one · 2024Article
- The Impact of COVID-19 on Trauma Emergency Patients in Southeastern Iran.Bulletin of emergency and trauma · 2024Article
- Real-time forecasting of COVID-19 spread according to protective behavior and vaccination: autoregressive integrated moving average models.BMC public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19, as the most significant epidemic of the century, infected 467 million people and took the lives of more than 6 million individuals as of March 19, 2022. Due to the rapid transmission of the disease and the lack of definitive treatment, countries have employed nonpharmaceutical interventions. This study aimed to investigate the effectiveness of the smart travel ban policy, which has been implemented for non-commercial vehicles in the intercity highways of Iran since November 21, 2020. The other goal was to suggest efficient COVID-19 forecasting tools and to examine the association of intercity travel patterns and COVID-19 trends in Iran. To this end, weekly confirmed cases and deaths due to COVID-19 and the intercity traffic flow reported by loop detectors were aggregated at the country's level. The Box-Jenkins methodology was employed to evaluate the policy's effectiveness, using the interrupted time series analysis. The results indicated that the autoregressive integrated moving average with explanatory variable (ARIMAX) model outperformed the univariate ARIMA model in predicting the disease trends based on the MAPE criterion. The weekly intercity traffic and its lagged variables were entered as covariates in both models of the disease cases and deaths. The results indicated that the weekly intercity traffic increases the new weekly COVID-19 cases and deaths with a time lag of two and five weeks, respectively. Besides, the interrupted time series analysis indicated that the smart travel ban policy had decreased intercity travel by around 29%. Nonetheless, it had no significant direct effect on COVID-19 trends. This study suggests that the travel ban policy would not be efficient lonely unless it is coupled with active measures and adherence to health protocols by the people.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.